ANNUAL REPORT

Company

Compass Therapeutics, Inc.

Filed

July 1, 2019

Period of Report

March 31, 2019

Accession Number

0001213900-19-011850

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →